Patents by Inventor L. Jane Jourdan

L. Jane Jourdan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290539
    Abstract: Described herein are engineered hemichannels, engineered vesicles that can contain the one or more of the engineered hemichannels, pharmaceutical formulations thereof, and uses thereof. In some aspects, the engineered vesicles can include one or more cargo molecules. Also described herein are methods of loading the engineered vesicles. In some aspects, loading of one or more cargo molecules engineered vesicles can be optionally via an engineered hemichannel contained in the engineered vesicle.
    Type: Application
    Filed: July 30, 2019
    Publication date: September 23, 2021
    Inventors: Robert G. GOURDIE, L. JANE JOURDAN, Eda ROGERS
  • Patent number: 10092624
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion. In some aspects, the therapeutic peptides may be used to treat a cancer such as, e.g., a pancreatic cancer or a glioblastoma.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: October 9, 2018
    Assignees: MUSC Foundation for Research Development, University of South Carolina
    Inventors: Robert G. Gourdie, Edie C. Goldsmith, L. Jane Jourdan, Joshua Matthew Rhett, Michael J. Yost
  • Publication number: 20160287663
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion from scar forming cells or fibroblasts. Also provided are methods for using the peptides to produce an anti-fibrotic, anti-scarring, anti-inflammatory, and/or pro-regenerative effect, e.g., on an injured or diseased tissue.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 6, 2016
    Applicants: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Robert G. GOURDIE, Edie C. GOLDSMITH, L. Jane JOURDAN, Joshua Matthew RHETT, Michael J. YOST
  • Patent number: 9345744
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion from scar forming cells or fibroblasts. Also provided are methods for using the peptides to produce an anti-fibrotic, anti-scarring, anti-inflammatory, and/or pro-regenerative effect, e.g., on an injured or diseased tissue.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: May 24, 2016
    Assignees: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Robert G. Gourdie, Edie C. Goldsmith, L. Jane Jourdan, Joshua Matthew Rhett, Michael J. Yost
  • Publication number: 20150174196
    Abstract: Provided are peptides that can inhibit collagen synthesis, processing and/or secretion from scar forming cells or fibroblasts. Also provided are methods for using the peptides to produce an anti-fibrotic, anti-scarring, anti-inflammatory, and/or pro-regenerative effect, e.g., on an injured or diseased tissue.
    Type: Application
    Filed: April 25, 2013
    Publication date: June 25, 2015
    Applicants: UNIVERSITY OF SOUTH CAROLINA, MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Robert G. Gourdie, Edie C. Goldsmith, L. Jane Jourdan, Joshua Matthew Rhett, Michael J. Yost